Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene vs Naloxone for Recurrent Respiratory Depression
NCT06408714Phase 3Withdrawn
- Sponsor
- The University of New Mexico
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalmefene in opioid overdose, sponsored by The University of New Mexico. Planned start Aug 2024; status: withdrawn.
02
Drugs
nalmefene
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT06408714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06408714.